Want to join the conversation?
$PM 2Q15 Call: On FY15 guidance, there is an incremental spending by accelerating 2016 launches of iQOS towards the beginning of the year. We are increasing the investment behind the combustible business. But I cannot quantify how much is the extra incremental spending, but will be above our guidance absent the additional investment.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.